James R McNab Net Worth & Insider Trades
James R McNab - Director, Titan Pharmaceuticals Inc
What is James R McNab's Net Worth?
The current estimated net worth of Titan Pharmaceuticals Inc's Director, James R McNab, is estimated to be about $10.5M . James R McNab owns about 300,000 units of Titan Pharmaceuticals Inc common stock. In the last 6 years at Titan Pharmaceuticals Inc, James R McNab has sold an estimated value of $0 worth.
What is James R McNab's Past Insider Trading?
James R McNab's largest purchase order was 20,000 units , worth over $140.6K on May 31, 2016. In total, James R McNab has made about 8 transactions over 6 years of their time at Titan Pharmaceuticals Inc. James R McNab usually trades in January, with the busiest year in 2017, 2016 and 2022. The most recent transaction was a purchase order of 200,000 units , worth over $50K on September 25, 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
James R McNab
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was James R McNab's Salary in 2020?
As Director of Titan Pharmaceuticals Inc, James R McNab has a total base salary of $544,900 . James R McNab received compensation valued at about $1,672,849 in 2020 after becoming Director.
What is James R McNab's' Mailing Address?
- Mailing address is C/o Curis, Inc 4 Maguire Road Lexington MA 02421 MA
What are Titan Pharmaceuticals Inc's Past Insider Trades?
Titan Pharmaceuticals Inc's most recent insider trade came on June 23, 2023 by David Lazar and Activist Investing Llc who sold 3,747,968 units worth $4.61M . In the last 8 years, insiders at Titan Pharmaceuticals Inc have sold an estimated value of $4.61M and bought an estimated value of $2.53M worth of shares. Insider trading is most common in February, with the busiest year in 2023. The most active traders at the company are Marc Rubin, Executive Chairman, James R McNab, Director, and Sunil Bhonsle, President and CEO .
TITAN PHARMACEUTICALS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||